NASDAQ Composite opens in less than two hours and Catalyst Pharmaceuticals’s pre-market value is already 1.89% up.

The last session, NASDAQ Composite ended with Catalyst Pharmaceuticals jumping 3.06% to $3.71. NASDAQ Composite dropped 0% to $13,635.99, after five successive sessions in a row of gains, on what was a somewhat positive trend exchanging session.

Catalyst Pharmaceuticals’s last close was $3.60, 42.32% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the present quarter and 5.5% for the next. The company’s growth estimates for the present quarter is 12.5% and a drop 20% for the next.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 1.94%, a positive 0.40%, and a positive 0.13%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.69%, 4.25%, and 4.14%, respectively.

LEAVE A REPLY

Please enter your comment!
Please enter your name here